Analysts at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The firm has a market cap of $833,000.00, a PE ratio of -0.01 and a beta of -0.90. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99.
Athersys Company Profile
Want More Great Investing Ideas?
Featured Stories
- Five stocks we like better than Athersys
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to Most Effectively Use the MarketBeat Earnings Screener
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
